These boring but beautiful picks will always have a place in my Stocks and Shares ISA

Harvey Jones is building his Stocks and Shares ISA around seven FTSE 100 dividend stocks that should slowly reveal their charms over time.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

My Stocks and Shares ISA has two roles. The first is to build up my wealth while I’m working. The second is to release income after I retire.

I’ve got some whizzy growth stocks in there, including cosmetics maker Warpaint and outsourcing firm Costain Group. But I’ve also got a heap of income-paying FTSE 100 blue-chips, and I’m pinning most of my hopes on them.

Today, they’re largely overlooked by investors, who would rather ride with the Magnificent Seven US tech heroes. My FTSE faves may be a little boring but they’re beautiful in their own way.

Should you invest £1,000 in Gsk right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Gsk made the list?

See the 6 stocks

FTSE 100 beauties

I prefer to buy stocks when they’re out of favour, rather than riding high. That allows me to pick them up at a discounted price, and secure an elevated yield.

My view is that UK dividend stocks would swing back into favour once interest rates peak and savings rates and bond yields fell. That scenario has taken longer to pan out than I hoped, but it should happen at some point. And when it does, I hope to bag some share price growth on top of my dividend income.

My favourite less-than-magnificent seven blue-chips are GSK (LSE: GSK), Lloyds Banking Group, Legal & General Group, M&G, Phoenix Group Holdings, Unilever and Taylor Wimpey.

They’re dull compared to, say, Nvidia and Tesla, but do offer the occasional flash of excitement.

The Taylor Wimpey share price is up 33.79% over the last year. And it still has a trailing yield of 6.1%. Lloyds is up 29.11% and yields 4.64% (that’s forecast to hit 5.5%).

Created with Highcharts 11.4.3Taylor Wimpey Plc + Lloyds Banking Group Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

The Phoenix share price has been boring for yonks but it does yield 9.92%. It was a beautiful day when the last dividend hit my portfolio.

Dividend income heroes

GSK‘s been interesting, but in the wrong way. I bought its shares in March and again in June, thinking it was due a share price recovery. So far, I’m down 10.73%. These are early days but I expected better. Over one year, they’re up 8.61%.

Created with Highcharts 11.4.3GSK PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

Pharmaceutical stocks are thought to be defensive but can also be volatile. Bringing new treatments to market is a tortuous process, with potential failure at every turn. Even the blockbuster successes will come off patent at some point, hitting sales, so exciting new treatments need to be found.

Plus there’s the threat of litigation. GSK’s heartburn treatment Zantac has been accused of causing cancer. News that cases would go to trial in the US knocked 10% off the GSK share price in a single day. It has yet to recover and probably won’t until the trial is done. And maybe not even then if the verdict goes the wrong way.

I’ll stick it out though. Over the longer run, I think GSK shares will come good, and today’s so-so 3.89% yield will finally recover.

These seven oh-so-boring stocks will sit in my Stocks and Shares ISA for years doing their thing. When I retire, I expect them to deliver a stream of tax-free income, and maybe some capital growth too. Beautiful.

But this isn’t the only opportunity that’s caught my attention this week. Here are:

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has positions in GSK, Legal & General Group Plc, M&g Plc, Phoenix Group Plc, and Taylor Wimpey Plc. The Motley Fool UK has recommended GSK and M&g Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 FTSE 100 and FTSE 250 stocks to consider as stock markets plummet!

Looking for lifeboats as growth-crushing trade tariffs loom? Here are two (including a FTSE 100 gold stock) I think merit…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

£10,000 invested in Watches of Switzerland shares 1 year ago is now worth…

Watches of Switzerland shares have been decimated by Trump’s tariffs on Switzerland. Dr James Fox explores whether this is an…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Investing Articles

Growth stocks are crashing! Here’s what I’m doing now

Our writer shares his thoughts as growth stocks get crushed, as well as a favourite from the Nasdaq that he…

Read more »

Investing Articles

What’s going on with the Nvidia share price now?

The Nvidia share price is tanking. Once the most valuable listed company, Nvidia has seen more than $1trn wiped off…

Read more »

Investing Articles

This FTSE AIM stock has £2.3bn in net cash, and a market cap of £2.4bn!

I love this FTSE AIM stock, but it really hasn’t delivered for me yet. The stock trades with crazily low…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

Down 15% in a week! Are these 5 FTSE 100 fallers screaming buys as markets plunge?

Five of Harvey Jones's favourite FTSE 100 stocks all have the same thing in common – they've fallen around 15%…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

2 stocks that have been crushed and now offer a ton of value

Edward Sheldon has been scanning the market for stocks that offer value after the sell-off. Here are two shares he…

Read more »